Drug Trial Radar · NCT07237308
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
586
Planned (sponsor's estimate)
Start
Jul 14, 2026
Primary completion
Jul 1, 2029
Study completion Aug 31, 2029
Sponsor
- Lead sponsor
- Yonsei UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial aims to compare the safety and efficacy of apixaban alone versus apixaban combined with clopidogrel in patients with acute ischemic stroke associated with non-valvular atrial fibrillation and concomitant symptomatic intracranial or extracranial atherosclerosis or complex plaque in the ascending aorta or aortic arch (≥4 mm in thickness, mobile, or ulcerated). Participants will be randomly assigned in a 1:1 ratio to receive apixaban monotherapy or dual therapy with clopidogrel for 30 days. The primary outcome is the incidence of new symptomatic or asymptomatic ischemic lesions on DWI/FLAIR at 30 (±5) days compared with baseline MRI, adjudicated by a central committee.
Conditions
- Stroke
- Ischemic
- Atrial Fibrillation
- Arteriosclerosis
- Intracranial Arteriosclerosis
Interventions
ApixabanDrug
Apixaban 5mg(or 2.5mg if indicated) twice daily. Used as monotherapy or in combination with clopidogrel for 30 days, then continued as monotherapy.
ClopidogrelDrug
Clopidogrel 75mg once daily for 30 days in combination with apixaban, then discontinued.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of new symptomatic or asymptomatic ischemic lesions on DWI/FLAIR at 30(±5) days compared with baseline MRI, adjudicated by a central committeeTime frame: At 30 ± 5 days after randomization
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Dong-A University Hospital
Busan, South Korea · Recruiting
Pusan National University Hospital
Busan, South Korea · Recruiting
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, South Korea · Recruiting
Keimyung University Dongsan Hospital
Daegu, South Korea · Recruiting
National Health Insurance Service Ilsan Hospital
Goyang, South Korea · Recruiting
Catholic Kwandong University International St. Mary's Hospital
Incheon, South Korea · Recruiting
Gachon University Gil Medical Center
Incheon, South Korea · Recruiting
Inha University Hospital
Incheon, South Korea · Recruiting
Ewha Womans University Seoul Hospital
Seoul, South Korea · Recruiting
Gangnam Severance Hospital
Seoul, South Korea · Recruiting
Hanyang University Seoul Hospital
Seoul, South Korea · Recruiting
Inje University Sanggye Paik Hospital
Seoul, South Korea · Recruiting
Kangbuk Samsung Hospital
Seoul, South Korea · Recruiting
Kangdong Sacred Heart Hospital
Seoul, South Korea · Recruiting
Korea University Anam Hospital
Seoul, South Korea · Recruiting
Kyung Hee University Hospital at Gangdong
Seoul, South Korea · Recruiting
Kyung Hee University Hospital
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Yonsei University College of Medicine
Seoul, South Korea · Recruiting
Yongin Severance Hospital
Yŏngin, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.